Internal Medicine, Endocrinology, Diabetes, & Metabolism · Saint Joseph, MI
NPI
1124469523
Since 2013
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
3950 Hollywood Rd
Saint Joseph, MI, 49085
Phone (269) 408-1600
Groups this clinician bills Medicare through
Medicare paid, 2024
$61K
943 services
Medicare patients, 2024
267
Average age 72
Drug cost, 2024
$3.1M
6,019 prescriptions
Company payments, 2025
$991
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amena Iqbal was code 99214 (office e&m - established), 325 times for 211 patients. In total Amena Iqbal billed 943 services in 12 codes, and Medicare paid $61K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-09-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 325 | 211 | $79.24 | $26K |
| 95251 Test - Miscellaneous | Office | 232 | 98 | $24.26 | $5,628 |
| 99215 Office E&M - Established | Office | 184 | 95 | $120.32 | $22K |
| 83036 Blood Count | Office | 93 | 70 | $9.42 | $876 |
| 99204 Office E&M - New | Office | 57 | 57 | $87.87 | $5,009 |
| 82962 Clinical Chemistry | Office | 26 | 25 | $3.09 | $80.25 |
By year: 2022 $41K for 674 services; 2023 $59K for 921 services; 2024 $61K for 943 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 93 | 70 | $9.42 | $876 |
| 82962 Clinical Chemistry | 26 | 25 | $3.09 | $80.25 |
Medicare prescription drug claims, 2024
In 2024, the drug Amena Iqbal prescribed most often to Medicare patients was Mounjaro (Tirzepatide), with 697 prescriptions and refills. In total Amena Iqbal wrote 6,019 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Mounjaro Tirzepatide | 697 | 790 | 128 | $813K |
| Levothyroxine Sodium Generic | 601 | 1,220 | 130 | $5,696 |
| Ozempic Semaglutide | 353 | 445 | 66 | $416K |
| Jardiance Empagliflozin | 298 | 509 | 70 | $290K |
| Metformin Hcl Er Metformin Hcl | 230 | 498 | 60 | $2,611 |
| Synthroid Levothyroxine Sodium | 227 | 383 | 41 | $15K |
| Methimazole Generic | 161 | 275 | 29 | $1,253 |
| Toujeo Solostar Insulin Glargine,hum.Rec.Anlog | 151 | 271 | 36 | $121K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 145 | 316 | 55 | $23K |
| Metformin Hcl Generic | 142 | 332 | 43 | $1,775 |
| Farxiga Dapagliflozin Propanediol | 137 | 247 | 30 | $133K |
| Glimepiride Generic | 134 | 215 | 29 | $718 |
| Humalog Kwikpen U-200 Insulin Lispro | 113 | 183 | 24 | $221K |
| Novolog Flexpen Insulin Aspart | 109 | 224 | 40 | $36K |
| Tresiba Flextouch U-100 Insulin Degludec | 107 | 254 | 39 | $81K |
Brand drugs: 3,301 claims; generic drugs: 2,285 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amena Iqbal $991 ($991 in general payments such as food, travel and fees) from 21 companies. The largest payer was Novo Nordisk Inc with $192.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 15 | $192 |
| Xeris Pharmaceuticals, Inc. | 6 | $167 |
| Ascendis Pharma Endocrinology Inc ASND | 4 | $74.69 |
| Abbvie Inc. ABBV | 4 | $70.52 |
| Amgen Inc. AMGN | 4 | $68.95 |
| Amneal Pharmaceuticals LLC AMRX | 3 | $58.12 |
| Abbott Laboratories ABT | 2 | $35.98 |
| Corcept Therapeutics CORT | 2 | $35.16 |
| Tandem Diabetes Care, Inc. TNDM | 2 | $33.68 |
| GlaxoSmithKline, LLC. GSK | 2 | $30.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.